Skip to main content
Clinical Trials/CTRI/2019/07/020070
CTRI/2019/07/020070Not yet recruitingNot Applicable

To Compare the efficacy and safety of Intradermal versus Intralesional Purified Protein Derivative (PPD) for treatment of Common warts in children

Himachal Pradesh University1 site in 1 country100 target enrollmentStarted: July 14, 2019Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
100
Locations
1
Primary Endpoint
Not yet recruiting

Study Overview

Brief Summary

I am going on intervention study include title to compare the efficacy and safety of Intradermal versus Intralesional Purified Protein Derivative (PPD) in treatment of Common warts in children.Dose schedule of PPD include 10TU per0.1 ml given intradermal and Intralesional at 2weekly interval upto 8weeks and asked patient to follow up at 12weeks to see resolution of warts.

Study Design

Study Type
Interventional
Allocation
Stratified randomization
Masking
Outcome Assessor Blinded

Eligibility Criteria

Ages
5.00 Year(s) to 15.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Children of age 5 to 15 years clinically diagnosed with common warts.

Exclusion Criteria

  • Patients with immune suppression from any disease or drug therapy.

Outcomes

Primary Outcomes

Not yet recruiting

Time Frame: Not yet recruiting

Secondary Outcomes

  • NA(NA)

Investigators

Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials

Comparative study of Intradermal versus... | Clinical Trial